Based on the above background, the present study investigated whether circulating inflammatory mediator CX3CL1 and D-dimer are associated with survival rates and prolonged illness among COPD patients with COVID-19. The gene discussed is CX3CL1; the disease is chronic obstructive pulmonary disease.